α-1-antichymotrypsin also acts as a negative regulator of pro-inflammatory cytokine production (e.g., TNF-α and IL-1β) and innate immunity, thus protecting against systemic inflammation (i.e., lethal endotoxemia and sepsis) (Wang and Sama, 2012). This evidence concerns the gene IL1B and serum lipopolysaccharide activity.